Molecular Fluorescence Endoscopy platform

DEVICE3 trials

Sponsors

University Medical Center Groningen

Conditions

Barrett EsophagusDysplasia in Barrett EsophagusEsophageal CancerPituitary AdenomaPituitary MacroadenomaPituitary Tumor

Phase 1

Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions

CompletedNCT03205501

University Medical Center GroningenBarrett Esophagus, Dysplasia in Barrett Esophagus, Esophageal Cancer

Start: 2017-02-09End: 2019-09-01Updated: 2024-04-16

Fluorescence Endoscopy of Esophageal Carcinoma

TerminatedNCT03558724

University Medical Center GroningenEsophageal Cancer

Start: 2018-10-29End: 2022-10-11Updated: 2024-04-16

Detection of PitNET Tissue During TSS Using Bevacizumab-800CW

CompletedNCT04212793

University Medical Center GroningenPituitary Adenoma, Pituitary Macroadenoma, Pituitary Tumor

Start: 2020-10-28End: 2022-10-24Updated: 2023-04-14

Related Papers

Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial].

2024-10-115 citations

Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial

BMJ Open2021-10-019 citations